Medications
How Long Does Semaglutide Stay in Your System? Ozempic and Wegovy Half-Life Explained
GLP-1 Companion · 7 min read
Quick answer
Semaglutide stays in your system far longer than most medications — its one-week half-life means the drug lingers for over a month after your last dose. Here is what that means in practice.
One of the most common questions from people on Ozempic or Wegovy is: how long does this drug actually stay in my system? The answer is longer than most people expect. Semaglutide — the active ingredient in both Ozempic and Wegovy — has a half-life of approximately 168 hours, or about one week. That makes it one of the longest-acting medications in its class, and it has real implications for how the drug works, what happens when you miss a dose, and how long side effects may persist after stopping.
What Is a Half-Life and Why Does It Matter?
A drug's half-life is the time it takes for the concentration in your bloodstream to fall by half. After one half-life, 50% of the drug remains. After two half-lives, 25%. After five half-lives, less than 4% remains — a level considered pharmacologically insignificant for most drugs.
For semaglutide, with its roughly one-week half-life, that math works out as follows:
- 1 week after last dose: ~50% of peak concentration remains
- 2 weeks after last dose: ~25% remains
- 3 weeks after last dose: ~12% remains
- 4 weeks after last dose: ~6% remains
- 5–7 weeks after last dose: concentration falls below 4% — effectively cleared
This is why semaglutide is dosed once weekly rather than daily. The long half-life maintains a steady, relatively stable drug level in the body between injections — unlike shorter-acting GLP-1 drugs such as liraglutide (Victoza/Saxenda), which must be injected daily.
How Is Semaglutide Designed to Last So Long?
The unusually long half-life of semaglutide is not accidental — it is the result of deliberate chemical engineering. Natural GLP-1, the hormone semaglutide mimics, is broken down in the body within minutes. Semaglutide was structurally modified in three key ways to resist this breakdown:
- A fatty acid chain is attached to the molecule, allowing it to bind strongly to albumin (a protein in blood). This albumin binding shields it from enzymes and keeps it circulating.
- Amino acid substitutions at two positions in the molecule prevent the enzyme DPP-4 from degrading it.
- The combination of these modifications drastically reduces kidney clearance.
The result is a molecule that is processed primarily by the liver and kidneys over weeks, not minutes or hours.
How Long Does It Take for Semaglutide to Build Up?
Just as it takes 5–7 weeks to clear semaglutide, it takes a similar amount of time for the drug to reach steady-state concentration — the stable plateau at which weekly doses replenish exactly what was cleared. This is why prescribers use a dose escalation schedule:
- Starting at 0.25 mg weekly for 4 weeks gives the body time to adjust to the drug before higher levels accumulate.
- Stepping up to 0.5 mg, then 1 mg, and potentially 1.7 mg or 2.4 mg (for Wegovy) allows gradual adaptation.
- Maximum weight-loss or blood-sugar benefits typically take several months to fully develop — not because the drug takes that long to work, but because effective weight loss and metabolic adaptation are inherently gradual processes.
What Happens If You Miss a Dose?
Because of semaglutide's long half-life, missing a single dose is generally less disruptive than missing a dose of a short-acting daily medication. Guidelines from the manufacturer indicate:
- If fewer than 5 days have passed since your scheduled injection day, take the missed dose as soon as you remember.
- If 5 or more days have passed, skip the missed dose and resume on your next regular weekly injection day.
- Do not take two doses to make up for a missed one.
The reason you can still take the missed dose within a 5-day window is that the drug has not fully cleared — adequate semaglutide from the previous dose is still circulating. After 5 days, the window for safe catch-up closes because taking the dose would then overlap too closely with the next scheduled injection.
How Long After Stopping Semaglutide Do Side Effects Last?
Many of the most common semaglutide side effects — nausea, reduced appetite, fatigue, constipation — are directly related to the drug's presence in the body. Since the drug takes 5–7 weeks to clear, some people continue to experience these effects for weeks after their last dose.
For most people, side effects begin to diminish noticeably within 1–2 weeks of stopping, as semaglutide concentration falls to lower levels. But individuals who are more sensitive to GLP-1 receptor activity may notice effects for 3–5 weeks after discontinuation.
Weight regain after stopping semaglutide follows a different timeline. The appetite-suppressing and metabolic effects wear off with the drug, and research shows that people tend to regain a significant portion of lost weight within 12 months of stopping — not because of the drug's half-life per se, but because the underlying drivers of weight gain (hunger signaling, metabolic set point) return when the drug is gone.
Semaglutide Half-Life vs. Other GLP-1 Medications
Not all GLP-1 receptor agonists are created equal when it comes to duration. Here is how semaglutide compares:
- Semaglutide (Ozempic, Wegovy): half-life ~168 hours (7 days) — dosed once weekly
- Tirzepatide (Mounjaro, Zepbound): half-life ~120–144 hours (5–6 days) — dosed once weekly
- Liraglutide (Victoza, Saxenda): half-life ~13 hours — dosed once daily
- Exenatide extended-release (Bydureon): half-life ~2 weeks — dosed once weekly as a microsphere depot
- Dulaglutide (Trulicity): half-life ~5 days — dosed once weekly
Semaglutide's half-life is among the longest of the standard injectable GLP-1 drugs, which is part of why its effect on appetite and blood sugar is considered particularly robust and consistent.
Does Semaglutide Affect a Drug Test?
Semaglutide is not a controlled substance and does not appear on standard urine drug screens used by employers or law enforcement. Standard drug panels test for substances such as opioids, benzodiazepines, amphetamines, cannabinoids, and cocaine — GLP-1 receptor agonists are not included.
If you are undergoing a specialized medical test or clinical trial that specifically measures peptide drug levels, semaglutide could be detected for weeks after stopping. However, this is not relevant to routine employment or legal drug testing.
Implications for Switching Medications
The long half-life of semaglutide has practical implications when switching to another GLP-1 drug or stopping the medication before a procedure:
- Switching from Ozempic to Wegovy (or vice versa): Because both contain semaglutide, switching typically requires no washout period. Your prescriber will simply adjust the dose for the new formulation.
- Switching from semaglutide to tirzepatide: Many practitioners begin tirzepatide immediately after the last semaglutide dose, relying on the long overlap period. Semaglutide will still be active at moderate levels for 2–3 weeks during early tirzepatide titration.
- Before surgery: Many anesthesia guidelines recommend stopping GLP-1 medications 1–7 days before elective procedures due to the risk of delayed gastric emptying and aspiration. However, because semaglutide takes 5–7 weeks to clear, stopping even a week before may not eliminate the drug's effects. Discuss with both your surgeon and prescriber.
The Bottom Line
Semaglutide's one-week half-life is not just a pharmacology footnote — it shapes everything from how you dose the medication to what happens when you miss an injection to how long you experience its effects after stopping. The drug stays in your system for 5–7 weeks after your last dose, providing a long, gradual tapering of activity. Understanding this can help you make more informed decisions about your treatment and know what to expect at each stage.
Sources
- Lau J et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. J Med Chem. 2015.
- Novo Nordisk. Ozempic (semaglutide) US Prescribing Information. 2023.
- Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide 2.4 mg. Diabetes Obes Metab. 2022.